Dr. Babar Bashir
Claim this profileThomas Jefferson University Hospital
Studies Solid Tumors
Studies Tumors
14 reported clinical trials
28 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Stage III
TAZ-CAMTA1 positive
2Tumors
Stage IV
Stage III
TAZ-CAMTA1 positive
Affiliated Hospitals
Thomas Jefferson University Hospital
Sidney Kimmel Cancer Center At Thomas Jefferson University
Clinical Trials Babar Bashir is currently running
ARTS-021
for Advanced Cancer
This study, the first clinical trial of AVZO-021, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and anti-tumor effects of AVZO-021 in patients with advanced solid tumors. AVZO-021 is an oral medication that inhibits cyclin-dependent kinase 2 (CDK 2).
Recruiting1 award Phase 1 & 2
LYL797
for Breast and Lung Cancer
This trial is testing a new treatment called LYL797, which uses modified immune cells to target and kill hard-to-treat breast and lung cancer cells. The study aims to find a safe dose and see how well it works in patients whose cancers have not responded to other treatments.
Recruiting1 award Phase 17 criteria
More about Babar Bashir
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Babar Bashir has experience with
- LYL797
- Nivolumab
- BT5528
- ELU001
- ARTS-021
- Ad5.F35-hGCC-PADRE
Breakdown of trials Babar Bashir has run
Solid Tumors
Tumors
Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Babar Bashir specialize in?
Babar Bashir focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is Babar Bashir currently recruiting for clinical trials?
Yes, Babar Bashir is currently recruiting for 7 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Babar Bashir has studied deeply?
Yes, Babar Bashir has studied treatments such as LYL797, Nivolumab, BT5528.
What is the best way to schedule an appointment with Babar Bashir?
Apply for one of the trials that Babar Bashir is conducting.
What is the office address of Babar Bashir?
The office of Babar Bashir is located at: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.